Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM4A92X)

Drug Name

MRL-953 Drug Info

Synonyms

SDZ-MRL-953

Indication

Disease Entry	ICD 11	Status	REF
Immune System disease	4A01-4B41	Terminated	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Interleukin 1 receptor type 2 (IL1R2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
GSK-1827771	DMA41JD	Rheumatoid arthritis	FA20	Phase 1	[3]
AMG 108	DMMUS8X	Rheumatoid arthritis	FA20	Discontinued in Phase 2	[4]
FR-133605	DMXWL0N	Arthritis	FA20	Terminated	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interleukin 1 receptor type 2 (IL1R2)	TT51DEV	IL1R2_HUMAN	Agonist	[2]

------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002036)
2	SDZ MRL 953, a lipid A analog as selective cytokine inducer. Prog Clin Biol Res. 1995;392:549-65.
3	WO patent application no. 2013,0077,63, Modulators of the nlrp3 inflammasome il-1ss pathway for the prevention and treatment of acne.
4	Clinical pipeline report, company report or official report of Amgen (2009).
5	Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. J Rheumatol. 1996 Oct;23(10):1778-83.